Ocrelizumab

ATC L04AG08 · 9 markets · 19 records

Ocrelizumab 9 markets · 19 records Forms

AU 5 records · 5 strengths

920 mg/23 mLinjectionOCREVUS SC also in GB·US·SG
300 mg/10 mLinjectionOCREVUS also in GB·US·SG
300 mginjectionOCREVUS ocrelizumab 300 mg/10 mL concentrate solution for infusion vial also in ES unknown
920 mginjectionOCREVUS SC ocrelizumab 920 mg/23 mL solution for injection vial unknown

Records without a stated strength · 1 OCREVUS

GB 3 records · 2 strengths

920 mg/23 mLinjectionOcrevus 920mg/23ml solution for injection vials also in AU·US·SG
300 mg/10 mLinjectionOcrevus 300mg/10ml concentrate for solution for infusion vials also in AU·US·SG

US 2 records · 2 strengths

920 mg/23 mLinjectionOcrevus Zunovo also in AU·GB·SG
300 mg/10 mLinjectionOCREVUS also in AU·GB·SG

SG 2 records · 2 strengths

920 mg/23 mLinjectionOCREVUS SOLUTION FOR INJECTION 920MG/23ML also in AU·GB·US
300 mg/10 mLinjectionOCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML also in AU·GB·US

CA 1 records · 1 strengths

30 mgliquidOCREVUS

ES 1 records · 1 strengths

300 mginjectionOCREVUS also in AU

MX 1 records · 1 strengths

Records without a stated strength · 1 OCREVUS SC

HK 1 records · 1 strengths

Records without a stated strength · 1 OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 OCREVUS

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	MX	HK	EU
920 mg/23 mL injection	Ocrevus Zunovo	Ocrevus 920mg/23ml solution for injection vials	not recorded	OCREVUS SC	OCREVUS SOLUTION FOR INJECTION 920MG/23ML	not recorded	not recorded	not recorded	not recorded
300 mg/10 mL injection	OCREVUS	Ocrevus 300mg/10ml concentrate for solution for infusion vials	not recorded	OCREVUS	OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML	not recorded	not recorded	not recorded	not recorded
300 mg injection	not recorded	not recorded	not recorded	OCREVUS ocrelizumab 300 mg/10 mL concentrate solution for infusion vial	not recorded	OCREVUS	not recorded	not recorded	not recorded
30 mg liquid	not recorded	not recorded	OCREVUS	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
920 mg injection	not recorded	not recorded	not recorded	OCREVUS SC ocrelizumab 920 mg/23 mL solution for injection vial	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	OCREVUS	not recorded	not recorded	not recorded	OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML	OCREVUS
not disclosed liquid	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	OCREVUS SC	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in CA · MX and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · MX que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · MX 有记录（未在本表显示）。另有 2 個規格/劑型僅在 CA · MX 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.